Prospera Financial Services’s Puma Biotechnology PBYI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Sell	158,762 -14,289	-8%	-$105K	0.02%	669
2026 Q1	$1.11M	Sell	173,051 -12,445	-7%	-$80.3K	0.02%	674
2025 Q4	$1.1M	Sell	185,496 -4,123	-2%	-$21.9K	0.02%	644
2025 Q3	$1.01M	Sell	189,619 -1,625	-0.8%	-$6.89K	0.02%	680
2025 Q2	$656K	Buy	191,244 +6,987	+4%	+$22.3K	0.01%	813
2025 Q1	$545K	Buy	184,257 +6,362	+4%	+$19.9K	0.01%	751
2024 Q4	$543K	Buy	177,895 +9,010	+5%	+$26.2K	0.01%	720
2024 Q3	$431K	Buy	168,885 +19,315	+13%	+$58.5K	0.01%	776
2024 Q2	$488K	Buy	149,570 +1,778	+1%	+$7.81K	0.01%	721
2024 Q1	$783K	Buy	147,792 +4,575	+3%	+$24.6K	0.02%	561
2023 Q4	$620K	Buy	143,217 +20,325	+17%	+$67.3K	0.02%	590
2023 Q3	$323K	Buy	122,892 +14,444	+13%	+$49.2K	0.01%	773
2023 Q2	$383K	Buy	108,448 +8,376	+8%	+$26.1K	0.01%	697
2023 Q1	$309K	Buy	100,072 +11,750	+13%	+$44.3K	0.01%	772
2022 Q4	$374K	Buy	88,322 +6,075	+7%	+$21K	0.02%	626
2022 Q3	$195K	Buy	82,247 +8,823	+12%	+$25.8K	0.01%	783
2022 Q2	$209K	Buy	73,424 +13,744	+23%	+$34.2K	0.01%	724
2022 Q1	$172K	Buy	59,680 +23,648	+66%	+$61.2K	0.01%	928
2021 Q4	$110K	Buy	36,032 +672	+2%	+$2.92K	﹤0.01%	847
2021 Q3	$248K	Buy	35,360 +9,615	+37%	+$72K	0.01%	712
2021 Q2	$236K	Buy	25,745 +3,977	+18%	+$40.3K	0.01%	722
2021 Q1	$212K	Buy	21,768 +2,940	+16%	+$32.8K	0.01%	708
2020 Q4	$193K	Buy	+18,828	New	+$191K	0.01%	647
2020 Q3	–	Sell	-12,186	Closed	-$127K	–	1675
2020 Q2	$127K	Buy	+12,186	New	+$126K	0.01%	558

Other funds holding PBYI